ArticleGynecologic oncology2020

Derangements in HUWE1/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma.

Elena Bonazzoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.